Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Geron Corporation - Common Stock (NQ:GERN)

1.170 +0.020 (+1.74%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Geron Corporation - Common Stock

< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Geron Oral Presentation at Upcoming ASCO Annual Meeting to Highlight Meaningful Continuous Transfusion Independence Observed in Imetelstat-Treated Lower Risk MDS Patients in IMerge Phase 3
From Geron Corporation
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Geron (GERN) Q1 2023 Earnings Call Transcript
GERN earnings call for the period ending March 31, 2023. 
Via The Motley Fool
Recap: Geron Q1 Earnings
 
Via Benzinga
A Preview Of Geron's Earnings
 
Via Benzinga
Looking Into Geron's Return On Capital Employed
 
Via Benzinga
The Latest Analyst Ratings for Geron
 
Via Benzinga
Geron Presentations at Upcoming EHA Annual Meeting to Report Updated Durability, Disease Modification and Favorable Patient Reported Outcomes (PRO) in Imetelstat-Treated Lower Risk MDS Patients in IMerge Phase 3
From Geron Corporation
Via Business Wire
Geron Corporation Reports First Quarter 2023 Financial Results and Business Highlights
From Geron Corporation
Via Business Wire
Geron to Announce First Quarter 2023 Financial Results on May 11, 2023
From Geron Corporation
Via Business Wire
Geron (GERN) Q4 2022 Earnings Call Transcript
GERN earnings call for the period ending December 31, 2022. 
Via The Motley Fool
Earnings Outlook For Geron
 
Via Benzinga
2 Top Healthcare Stocks to Buy Right Now
One has a breakout drug, the other a nice-sized moat. 
Via The Motley Fool
Geron Announces Upcoming Oral Presentation at 2023 American Society of Clinical Oncology Annual Meeting of Imetelstat Data from IMerge Phase 3 Lower Risk MDS Trial
From Geron Corporation
Via Business Wire
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Why Shares of Geron Are Up 30% This Week
The company's CEO was scheduled to speak at a virtual conference on Thursday. 
Via The Motley Fool
Geron to Present at Upcoming Investor Conferences in April
From Geron Corporation
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For March 28, 2023
 
Via Benzinga
7 Biotech Stocks Sitting in the Sweet Spot
Biotech stocks have the potential for massive profits if their companies are successful in developing drugs that are safe and marketable. 
Via InvestorPlace
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
Geron Corporation Reports Fourth Quarter and Full Year 2022 Financial Results and Upcoming Milestones
From Geron Corporation
Via Business Wire
Geron to Announce Fourth Quarter and Full-Year 2022 Financial Results on March 16, 2023
From Geron Corporation
Via Business Wire
SMID Cap Life Science Update: Are You An Investor Or Trader?
Despite choppy trading, there is an upward tilt to life science stocks since the 9/26/22 lows. 
Via Talk Markets
7 A-Rated Penny Stocks Worth Betting On
Penny stocks tend to be more volatile than more so-called “established” stocks, so you have to be comfortable with your risk tolerance. 
Via InvestorPlace
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From Geron Corporation
Via Business Wire
7 A-Rated Healthcare Stocks to Buy for the Future of Medicine
Snapping up or adding to your positions in these healthcare stocks could be just what the doctor ordered for your portfolio. 
Via InvestorPlace
7 A-Rated Stocks to Buy for February 2023
Now's the time to pounce on these seven high-quality stocks to buy; each one earns an A rating in Portfolio Grader. 
Via InvestorPlace
When Small Cap Biotechs Lose Momentum: Are You An Investor Or A Trader?
A few small cap biotechs lost momentum last week so now might be the time to take profits. But many of these stocks are favored because of their core technology and favored by funds; time to buy? 
Via Talk Markets
7 A-Rated Stocks to Buy for Less Than $25
These seven stocks to buy for less than $25 per share are strong opportunities in today's resilient yet uncertain market. 
Via InvestorPlace
< Previous 1 2
...
8 9 10 11 12 13 14 15 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS